Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 432,060 shares at $71.15 ($30.6M) on 2024-09-20, disclosed to the SEC on 2024-09-20.
Scheduled sale ($30.6M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.43 | 96,056 | $6.8M | 22.1% |
| 2 | $70.43 | 96,056 | $6.8M | 22.1% |
| 3 | $71.15 | 119,874 | $8.5M | 27.9% |
| 4 | $71.15 | 119,874 | $8.5M | 27.9% |
| 5 | $71.99 | 200 | $14K | 0.0% |
| Total | $70.83 avg | 432,060 |
| $30.6M |
| 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |